Abiopharma

🔍 Mastrototaro John (Executive)

Company: Movano Inc. (MOVE)

Report Date: 2026-01-05

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Stock at $1.25 per share (Direct)
  Date: 2026-01-05 | Code: M | equity_swap_involved: false | shares_owned_after: 6,944.00 | transaction_form_type: 4
• Sold 2,514 shares of Common Stock at $8.21 per share (Direct)
  Date: 2026-01-05 | Code: S | equity_swap_involved: false | shares_owned_after: 4,430.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,000 shares of Stock Options (Right to Buy) at $1.25 per share (Derivative)
  Date: 2026-01-05 | Code: M | Expires: 2026-03-15 | equity_swap_involved: false | shares_owned_after: 72,834.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025.
• F2: This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025.